Human Subjects Review Board Approval

DEPARTMENT OF HEALTH & HUMAN SERVICES

Public Health Service
Centers for Disease Control
and Prevention (CDC)

Memorandum
Date

July 20, 2017

From

Kathy Masterson, CIP
IRB Administrator, NIOSH Institutional Review Board

Subject

IRB Approval of Continuation of NIOSH Protocol 14-DSR-02XP, “Anthropometric
Information on Law Enforcement Officers” (Expedited)

To

Hongwei Hsiao, PhD
Project Officer, DSR, NIOSH
The NIOSH IRB has reviewed and approved your request to continue protocol 14-DSR-02XP
for the maximum allowable period of one year and it will expire on July 15, 2018. The
protocol was reviewed in accordance with the expedited review process outlined in 45 CFR
46.110(b)(1), Categories (4), (6) and (7).
The IRB determined that the study poses no more than minimal risk to subjects.
If other institutions involved in this protocol are being awarded NIOSH funds through the CDC
Procurement and Grants Office (PGO), you are required to send a copy of this IRB approval to
the CDC PGO award specialist handling the award. You are also required to verify with the
award specialist the awardee has provided PGO with the required documentation and has
approval to begin or continue research involving human subjects as described in this protocol.
As a reminder, the IRB must review and approve all human subjects research protocols at
intervals appropriate to the degree of risk, but not less than once per year. There is no grace
period beyond one year from the last IRB approval date. It is ultimately your responsibility to
submit your research protocol for continuation review and approval by the IRB along with
available IRB approvals from all collaborators. Please keep this approval in your protocol file
as proof of IRB approval and as a reminder of the expiration date. To avoid lapses in
approval of your research and the possible suspension of subject enrollment and/or
termination of the protocol, please submit your continuation request along with all
completed supporting documentation at least six weeks before the protocol's expiration
date of July 15, 2018.
Any problems of a serious nature must be brought to the immediate attention of the
NIOSH IRB, and any proposed changes to the protocol should be submitted as an
amendment to the protocol for NIOSH IRB approval before they are implemented.
If you have any questions, please contact the CDC Human Research Protection Program
(513)533-8591 or e-mail: [email protected].